Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
SAGE Therapeutics (SAGE) has provided an update.
Steven Paul, M.D., a board member of Sage Therapeutics, Inc., has announced his retirement from the board effective at the end of his term, coinciding with the 2024 annual stockholders’ meeting. His departure is amicable, with no disagreements on company operations, policies, or practices cited as reasons for his decision.
Find detailed analytics on SAGE stock on TipRanks’ Stock Analysis page.